Redx Pharma: Director dealings: Redx Pharma CEO ups stake
Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.
Read full article »
Redx Pharma is an England-based biotechnology company that discovers and develops novel drugs for the treatment of cancer and fibrosis.
Read more